Yankcom Partnership Astrazeneca PLC Transaction History

Yankcom Partnership

$235 Billion
Q4 2025

A detailed history of Yankcom Partnership transactions in Astrazeneca PLC stock. As of the latest transaction made, Yankcom Partnership holds 342 shares of AZN stock, worth $30,574. This represents 0.01% of its overall portfolio holdings.

Number of Shares

342

Holding current value

$30,574

% of portfolio

0.01%

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2025 Jan 20, 2026	BUY	$81.15 - $89.4 $27,753 - $30,574	342 New	342 $31.4 Million

Others Institutions Holding AZN

# of Institutions

1,541

Shares Held

503M

Call Options Held

5.59M

Put Options Held

3.18M

Price T Rowe Associates Inc Baltimore, MD

49.1M
Shares

$4.39 Billion
0.4% of portfolio
Primecap Management CO Pasadena, CA

39.9M
Shares

$3.56 Billion
2.42% of portfolio
Bank Of America Corp Charlotte, NC

32.6M
Shares

$2.92 Billion
0.18% of portfolio
Wellington Management Group LLP Boston, MA

32.3M
Shares

$2.89 Billion
0.45% of portfolio
Capital International Investors Los Angeles, CA

25.1M
Shares

$2.24 Billion
0.33% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Yankcom Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Yankcom Partnership with notifications on news.

Account